<DOC DOCNO="nw/wsj/13/wsj_1392@1392@wsj@nw@en@on">
<TEXT PARTNO="000">
<COREF ID="10" TYPE="IDENT"><COREF ID="11" TYPE="APPOS" SUBTYPE="HEAD">Roche Holding AG</COREF> , <COREF ID="11" TYPE="APPOS" SUBTYPE="ATTRIB">parent of the Swiss chemical and pharmaceutical group</COREF> ,</COREF> said 0 <COREF ID="10" TYPE="IDENT">its</COREF> group sales rose 22 % in the first nine months of <COREF ID="14" TYPE="IDENT">the year</COREF> to <COREF ID="12" TYPE="APPOS" SUBTYPE="HEAD">7.32 billion francs</COREF> -LRB- <COREF ID="12" TYPE="APPOS" SUBTYPE="ATTRIB">$ 4.51 billion</COREF> *U* -RRB- .
<COREF ID="10" TYPE="IDENT">The company</COREF> reported good gains in all of <COREF ID="10" TYPE="IDENT">its</COREF> divisions .
<COREF ID="10" TYPE="IDENT">Roche</COREF> also said 0 <COREF ID="10" TYPE="IDENT">it</COREF> expects a `` considerable rise '' in <COREF ID="14" TYPE="IDENT">1989</COREF> group profit from the 641.5 million - franc -LRB- $ 396 million *U* -RRB- net in 1988 .
</TEXT>
</DOC>
